UAE healthcare industry has witnessed high development over the past years and has attracted various international players to the market. The region is engaged in building of large healthcare infrastructure and medical cities to raise the supply and quality of healthcare in the country.
Healthcare segment is considered as priority segment by the Government of the UAE and the segment has experienced tremendous growth in the recent years. Presence of multinational diverse population, high prevalence of chronic diseases, aging population and growing medical tourism in the region is the major factor which has led to increased spending on healthcare in the country.
Mandate health insurance for Dubai inhabitant regulation by DHA in 2014 impacted the revenues of the hospitals in a positive manner. The insurance provided freedom to residents to opt for treatment and diagnostic procedures without any fear of cost of the procedure, benefiting the overall revenue of UAE hospitals market.
Abu Dhabi dominated the UAE hospitals market, by value in 2015. Presence of large number of hospitals in the region to cater region’s maximum population percentage in the country.
Big players operating in medical devices and pharmaceuticals market could plan to set up their manufacturing unit in the country. This would decrease the price of the goods as it would save the import duties and margins of the importers. Moreover, awareness about the company and customer loyalty would also increase leading to increase in demand for products
The overall cost of health insurance premiums is increasing at a rapid pace. It has been observed that the overall cost of premiums rose recording an increase of more than 12%. The cost of premiums is also outstripping the cost of healthcare itself, which is estimated to have risen by about 9% a year between 2008 and 2013.
Multi-specialty hospitals dominated the hospitals market with high revenue share in 2015, owing to their benefit to get consultation from doctors with diverse specialties. Additionally, the UAE hospitals market was in growing phase in these six years and therefore there were less number of hospitals in the region. Therefore, the Ministry of Health and private healthcare providers focused on multi-specialty hospitals to cater with all the disease conditions in the vicinity of hospitals.
Al Borg Medical Laboratories has a fleet of vehicles used for serving the need of customers from clinics, polyclinics, and hospitals. The vehicles are used for collection of sample from the patient’s respective place in accordance with international standards. These cars are monitored through GPS technology to guarantee accuracy and timely tracking of their shipment.
Rising population, elevating medical tourism sector and growing prevalence of lifestyle associated chronic diseases are leading to an increased strain on medical institutions to provide quality healthcare solutions to residents, expats and tourists in UAE. Telemedicine, which utilizes digital technologies to provide healthcare solutions from any location in the country proved out to be solution for this. Telemedicine would assist in relieving the shortage of quality healthcare practitioners by expanding the reach of UAE physicians and by providing access to general and specialist care in affordable cost.
UAE home healthcare market is growing at a rapid pace owing to the aging population, stable economic position of people to opt for expensive home healthcare service solutions, and rising investments by public and private players in home healthcare market. Germany based equity investment group such as TVM Capital had also invested into home healthcare market with the establishment of Manzil Healthcare in 2011.
Prescribed drugs hold the major share of the UAE pharmaceuticals market. High prevalence of chronic diseases in the region, which requires prescriptions and cannot be treated with the help of OTC drugs, is the major factor which has led to the dominance.
Various healthcare industry giants such as GE Healthcare, Philips Medical Systems, Siemens Healthcare and many others in partnerships is increasing the awareness and demand for advance medical equipments.
Neopharma in terms of revenue share was one of the leading companies in the market in 2015. The company’s partnership with Pfizer and Merck Serono has resulted in revenue generation for the company. Partnership with Pfizer helped the company in increasing its generic product portfolio and through Merck Serono, Neopharma generated revenue by manufacturing branded drugs for company to cater UAE market.
Rising awareness about the pre-pregnancy tests is the major factor which has contributed towards the revenue of the medical diagnostic laboratories in the UAE. Various market players have also provided packages in low cost and advanced pre-pregnancy test during these years, boosting the demand for pre-pregnancy tests.
Scope Of UAE Healthcare Market
Market Potential
Market Segmentation
Medical Devices Market
Pharmaceuticals Market
Pharmacy Retail Market
Hospitals Market
Independent Diagnostic Laboratories Market
UAE Clinics/Polyclinics Market
UAE Telemedicine Market
UAE Home Healthcare Market
Macroeconomic Factors
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Approach – Market Sizing
Market Sizing – Overall Healthcare Market
Market Sizing – Medical Devices and Pharmaceuticals Market
Market Sizing – Hospitals Market
Market Sizing – Independent Diagnostic Laboratories Market
Market Sizing – Telemedicine Market
Market Sizing – Home Healthcare Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Limitations
Final Conclusion
3. UAE Healthcare Market, CY2010 – CY2015
3.1. UAE Healthcare Statistics
3.2. UAE Healthcare Regulatory Bodies
3.3. Health Insurance in UAE
3.4. UAE Imports Scenario
3.4.1. UAE Imports Procedure
3.4.2. Essential Documents for Imports of Goods into UAE
3.5. UAE Healthcare Market Size, CY2010 – CY2015
4. UAE Medical devices Market Size By Value, CY2010 -CY2015
4.1. UAE Medical Devices Market Segmentation, CY2010 – CY2015
4.1.1. By Type of Application,
4.1.2. By Institutional and Household Demand, CY2010 – CY2015
4.1.3. By Domestic Demand and Imports, CY2010 – CY2015
4.1.4. By Emirates, CY2015
4.2. Imports of Medical Devices in UAE
4.2.1. Import Duties
4.2.2. Segmentation of Imported Medical Devices in UAE, CY2012 – CY2014
By Type of Products, CY2012 – CY2014
By Major Countries, CY2012 – CY2014
4.3. Exports of Medical Devices by UAE
4.3.1. Segmentation of Exported Medical Devices in UAE, CY2012 – CY2014
By Type of Products, CY2012 – CY2014
By Major Countries, CY2012 – CY2014
4.4. Regulatory Environment for Medical Devices in UAE
4.5. Trends and Developments in UAE Medical Devices Market
4.5.1. Rising Investments on Healthcare Infrastructure
4.5.2. Partnerships with Medical Devices Giants
4.5.3. Growing Demand for Wearable Smart Medical Devices
4.5.4. Demand for Innovative Products in the UAE
4.6. UAE Medical Devices Market Competitive Landscape
4.6.1. Company Profiles for Importers in UAE Medical Devices Market
Gulf Drug LLC
Abu Dhabi International Medical Services (ADI)
Modern Pharmaceutical Company Healthcare (MPC)
Pharmatrade LLC
Atlas Medical
4.7. Market Share of Major Market Players in UAE Medical Devices Market, CY2015
4.7.1. Importers
4.7.2. Manufacturers
4.8. Decision Making Process to Shortlist Medical Device
4.9. Future Outlook and Projections, CY2016 – CY2020
5. UAE Pharmaceuticals Market Size by Value, CY2010 – CY2015
5.1. UAE Pharmaceuticals Market Segmentation
5.1.1. By Generic and Patented Drugs, CY2010 – CY2015
5.1.2. By OTC and Prescribed Drugs, CY2010 – CY2015
5.1.3. By Domestic Demand and Imports, CY2010 – CY2015
5.1.4. By Therapeutic Area, CY2010 – CY2015
5.1.5. By Emirates, CY2015
5.2. Imports of Pharmaceuticals in UAE
5.2.1. Import Duties
5.2.2. Segmentation of Imported Pharmaceuticals, CY2010 – CY2014
By Type of Products, CY2012 – CY2014
By Major Countries, CY2010 – CY2014
5.3. Exports of Pharmaceuticals by UAE
5.3.1. Segmentation of Exported Medical Devices in UAE, CY2010 – CY2014
By Type of Products, CY 2010 – CY2014
By Major Countries, CY2012 – CY2014
5.4. Regulatory Environment for Pharmaceuticals in UAE
5.5. UAE Patent Approval Procedure
5.6. Trends and Developments in UAE Pharmaceuticals Market
5.6.1. Establishment of Free Zone, DuBiotech
5.6.2. Rising Generic Drug Production
5.6.3. Slashing Drugs Prices in the UAE
5.7. UAE Pharmaceuticals Market Competitive Landscape
5.7.1. Company Profiles for Domestic Manufacturers in UAE Pharmaceuticals Market
Julphar
Neopharma
Globalpharma
Medpharma
5.8. Market Share of Major Market Players in UAE Pharmaceuticals Market, CY2015
5.8.1. Domestic Manufacturers
5.8.2. Importers
5.8.3. International Manufacturers
5.9. Key Pharmaceutical Products Launched in UAE, CY2010 – CY2015
5.10. Future Outlook and Projections, CY2016 – CY2020
To know more on coverage, click on the link below:
https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-market-report/37505-91.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
query@kenresearch.com
+91-124-4230204
